Steven Cohen’s Phibro Animal Health PAHC Stock Holding History

Steven Cohen’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,482	Closed	-$1.08M	–	4444
2026 Q1	$1.08M	Sell	19,482 -14,373	-42%	-$684K	﹤0.01%	2721
2025 Q4	$1.26M	Buy	+33,855	New	+$1.38M	﹤0.01%	2749
2025 Q2	–	Sell	-27,443	Closed	-$586K	–	2491
2025 Q1	$586K	Buy	+27,443	New	+$613K	﹤0.01%	1583
2023 Q4	–	Sell	-66	Closed	-$837	–	2651
2023 Q3	$837	Buy	+66	New	+$936	﹤0.01%	2371

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steven Cohen's PAHC Position: Q2 2026 in Review

Steven Cohen sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 19,482 shares — an estimated $1.08M sold.

Steven Cohen first reported a position in PAHC in Q3 2023 and held it in 4 quarters. The position peaked at $1.26M in Q4 2025. 207 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Steven Cohen reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 19,482 Phibro Animal Health shares in Q2 2026, an estimated $1.08M.
Steven Cohen first reported a position in Phibro Animal Health in Q3 2023 and held it in 4 quarters.
Steven Cohen's Phibro Animal Health position peaked at $1.26M in Q4 2025.
207 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.